Cohance Lifesciences Limited (NSE:COHANCE)
India · Delayed Price · Currency is INR 429.40
-2.10 (-0.49%)
Jun 1, 2026, 3:29 PM IST
Cohance Lifesciences Market Cap
Cohance Lifesciences has a market cap or net worth of 164.27 billion as of June 1, 2026. Its market cap has decreased by -60.16% in one year.
Market Cap
164.27B
Enterprise Value
166.24B
Revenue
22.69B
Ranking
n/a
PE Ratio
91.75
Stock Price
429.40
Market Cap Chart
Since March 9, 2020, Cohance Lifesciences's market cap has increased from 33.71M to 164.27B, an increase of 487,288.61%. That is a compound annual growth rate of 291.26%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 29, 2026 | 165.08B | -18.37% |
| Dec 31, 2025 | 202.22B | -30.24% |
| Dec 31, 2024 | 289.89B | 57.55% |
| Dec 29, 2023 | 184.00B | 46.05% |
| Dec 30, 2022 | 125.98B | 0.33% |
| Dec 31, 2021 | 125.56B | 9.05% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Mar 9, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Ajanta Pharma | 365.78B |
| Wockhardt | 330.09B |
| Emcure Pharmaceuticals | 321.54B |
| Piramal Pharma | 229.44B |
| Eris Lifesciences | 193.86B |
| NATCO Pharma | 181.96B |
| Alembic Pharmaceuticals | 144.69B |
| Alivus Life Sciences | 129.55B |